{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T04:06:34Z","timestamp":1747713994487,"version":"3.40.5"},"reference-count":10,"publisher":"FapUNIFESP (SciELO)","issue":"6 suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:p>The change in immunological response obtained by immunobiologics has brought a new paradigm to the treatment of immune-mediated disorders. As a result of their efficacy, there is a positive impact on the quality of life of patients. However, severe side effects, such as demyelination of cerebral or peripheral nerves, have been reported. After review of literature using PubMed and MEDLINE data from 2000 to 2012, we identified the cases correlating the biological uniterms and optic neuritis. This article reports the first Brazilian optic neuritis case associated with the use of immunobiologics. This publication is justified by the rarity of the disease and atypical therapeutical evolution.<\/jats:p>","DOI":"10.1590\/abd1806-4841.20132295","type":"journal-article","created":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T19:47:08Z","timestamp":1391111228000},"page":"162-165","source":"Crossref","is-referenced-by-count":4,"title":["Optic neuritis due to immunobiologics: first Brazilian case report"],"prefix":"10.1590","volume":"88","author":[{"given":"Luiz Gustavo Martins da","family":"Silva","sequence":"first","affiliation":[{"name":"Universidade do Oeste Paulista,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Let\u00edcia Soares","family":"Sasso","sequence":"additional","affiliation":[{"name":"Universidade do Oeste Paulista,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Jos\u00e9","family":"Nelli","sequence":"additional","affiliation":[{"name":"Universidade do Oeste Paulista,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Bernardes Filho","sequence":"additional","affiliation":[{"name":"Rio de Janeiro Santa Casa da Miseric\u00f3rdia Professor Rubem David Azulay Institute of Dermatology Hospital,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilda Aparecida Milanez Morgado de","family":"Abreu","sequence":"additional","affiliation":[{"name":"Universidade do Oeste Paulista,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"year":"2009","series-title":"Consenso Brasileiro de Psor\u00edase 2009","key":"ref1"},{"key":"ref2","series-title":"Rook's Textbook of Dermatology","first-page":"20.1","volume-title":"Psoriasis","author":"Griffiths CEM","year":"2010","edition":"8th. ed"},{"key":"ref3","first-page":"257","article-title":"Moderate to severe psoriasis treated with infliximab - 53 patients: patients profile, efficacy and adverse effects","volume":"86","author":"Duarte AA","year":"2011","journal-title":"An Bras Dermatol"},{"key":"ref4","first-page":"493","article-title":"Psoriasis in the era of biologics","volume":"23","author":"Torres T","year":"2010","journal-title":"Acta Med Port"},{"key":"ref5","first-page":"535","article-title":"Infliximab in treatment of severe psoriatic arthritis","volume":"80","author":"Loyola AJC","year":"2005","journal-title":"An Bras Dermatol"},{"key":"ref6","first-page":"997","article-title":"Future perspectives in the treatment of psoriasis: news in biological therapies","volume":"24","author":"Diamantino F","year":"2011","journal-title":"Acta Med Port"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00415-010-5591-7","article-title":"Neurological adverse events associated with anti-tumor necrosis factor alpha treatment","volume":"257","author":"Tristano AG","year":"2010","journal-title":"J Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00417-009-1227-y","article-title":"Infliximab and anterior optic neuropathy: case report and review of the literature","volume":"248","author":"Chan JW","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/ard.2006.066787","article-title":"Optic neuritis occurring with anti-tumor necrosis factor therapy","volume":"66","author":"Simsek I","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"ref10","series-title":"Oftalmologia Cl\u00ednica","first-page":"785","volume-title":"Neuroftalmologia","author":"Kanski JJ","year":"2008","edition":"6 ed"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v88n6s1\/0365-0596-abd-88-06-s1-0162.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:41Z","timestamp":1747666841000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962013000800162&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":10,"journal-issue":{"issue":"6 suppl 1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0365-05962013000800162"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20132295","relation":{},"ISSN":["0365-0596"],"issn-type":[{"type":"electronic","value":"0365-0596"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}